Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer

Documenti analoghi

• Clinical impact of endogenous luteinizing hormone in frozen–thawed embryo transfer during hormone replacement cycle without gonadotropin‐releasing hormone analog coadministration: Effects on pregnancy outcomes
  di: Akiko Sakata, et al.
  Pubblicazione: (2024)
• Differences in perinatal complications and serum hormone levels due to uterine endometrial preparation methods in frozen–thawed embryo transfer
  di: Tatsuya Yoshihara, et al.
  Pubblicazione: (2024)
• A retrospective observational study of changes in uterine fibroid blood flow and fibroid diameter after administration of gonadotropin‐releasing hormone agonists and antagonists using superb microvascular imaging
  di: Yudai Tanaka, et al.
  Pubblicazione: (2025)
• Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk?
  di: John A. Eden
  Pubblicazione: (2024)
• Correction to “Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle‐stimulating hormone/luteinizing hormone ratios during in vitro fertilization”
  Pubblicazione: (2024)